AAAAAA
Results:
1-7
|
Results: 7
Authors:
Jensen, LH
Nitiss, KC
Rose, A
Dong, JW
Zhou, JF
Hu, T
Osheroff, N
Jensen, PB
Sehested, M
Nitiss, JL
Citation: Lh. Jensen et al., A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines, J BIOL CHEM, 275(3), 2000, pp. 2137-2146
Authors:
Jensen, LH
Wessel, I
Moller, M
Nitiss, JL
Sehested, I
Jensen, PB
Citation: Lh. Jensen et al., N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance, FEBS LETTER, 480(2-3), 2000, pp. 201-207
Authors:
Teuber, L
Watjen, F
Jensen, LH
Citation: L. Teuber et al., Ligands for the benzodiazepine binding site - a survey, CUR PHARM D, 5(5), 1999, pp. 317-343
Authors:
Mikkelsen, M
Moller, A
Jensen, LH
Pedersen, A
Harajehi, JB
Pakkenberg, H
Citation: M. Mikkelsen et al., MPTP-induced parkinsonism in minipigs: A behavioral, biochemical, and histological study, NEUROTOX T, 21(2), 1999, pp. 169-175
Authors:
Gronborg, M
Johansen, TE
Peters, D
Ahring, PK
Drejer, J
Moller, A
Jensen, LH
Citation: M. Gronborg et al., Neuroprotection by a novel compound, NS521, J PHARM EXP, 290(1), 1999, pp. 348-353
Authors:
Nielsen, EO
Varming, T
Mathiesen, C
Jensen, LH
Moller, A
Gouliaev, AH
Watjen, F
Drejer, J
Citation: Eo. Nielsen et al., SPD 502: A water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity, J PHARM EXP, 289(3), 1999, pp. 1492-1501
Authors:
Wessel, I
Jensen, LH
Jensen, PB
Falck, J
Rose, A
Roerth, M
Nitiss, JL
Sehested, M
Citation: I. Wessel et al., Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform, CANCER RES, 59(14), 1999, pp. 3442-3450
Risultati:
1-7
|